Why the study?
Elevated STAT3 activity is implicated in diabetic cardiomyopathy, and the authors hypothesized its fibrosis-promoting and hypertrophic actions are linked to activation by EGFR.
Does blockade of STAT3 or EGFR attenuate cardiomyopathy in STZ-induced type 1 diabetic mice and cultured cardiomyocytes?
Does blockade of STAT3 or EGFR attenuate cardiomyopathy in STZ-induced type 1 diabetic mice and cultured cardiomyocytes?
Inhibition of the EGFR-STAT3 signaling axis attenuates structural and functional deficits in a mouse model of diabetic cardiomyopathy, suggesting a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for EGFR-STAT3 targeting in diabetic cardiomyopathy; leaves open any clinical relevance or therapeutic translation.
Emerging evidence implicates elevated activity of STAT3 transcription factor in driving the development and progression of diabetic cardiomyopathy (DCM). We hypothesized that the fibrosis-promoting and hypertrophic actions of STAT3 are linked to the activation by epidermal growth factor receptor (EGFR). We tested this hypothesis by challenging cultured cardiomyocytes to high-concentration glucose and heart tissues of streptozotocin (STZ)-induced type 1 diabetic mice. Our results indicated that, in diabetic mice, the blockade of STAT3 or EGFR using selective inhibitors S3I-201 and erlotinib, respectively, abrogated the increased activating STAT3 phosphorylation and the induction of genes regulating fibrosis and hypertrophy in myocardial tissue. S3I-201 and erlotinib significantly reduced myocardial structural and functional deficits in diabetic mice. In cultured cardiomyocytes, high-concentration glucose induced EGFR-mediated STAT3 phosphorylation. We further showed that blockade of STAT3 or EGFR using selective inhibitors and siRNAs significantly reduced the increased expression of genes known to promote fibrosis and hypertrophy in cardiomyocytes. These results provide novel evidence that the EGFR-STAT3 signaling axis likely plays a crucial role in the development and progression of DCM.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: